Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

February 23, 2026 11:45 ET | Source: ARGAN

ARGAN: INFORMATION REGARDING THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES COMPOSING THE SHARE CAPITAL ON FEBRUARY 18, 2026

Press release – Neuilly-sur-Seine, Monday, February 23, 2026 – 5.45pm Information regarding the total number of voting rights and shares composing the share capital on February 18, 2026 On February...
February 23, 2026 10:49 ET | Source: Precedence Research

Polymers Market Size to Reach USD 1,424.98 Billion by 2035 - Exclusive Report by Towards Chemical and Materials

The polymers market size is projected to grow from USD 885.38 billion in 2026 to USD 1,424.98 billion by 2035, at a CAGR of 5.43%.
February 23, 2026 10:27 ET | Source: Blueprint Enterprises

Blueprint Enterprises Establishes Homefield Sports Group and Announces Inaugural Acquisition

Blueprint Enterprises establishes Homefield Sports Group - a platform dedicated to investing in and scaling recreational sports organizations.
February 23, 2026 10:17 ET | Source: Research and Markets

Microfluidic Components Market Size, Trends, Value Chain and Competition Forecast 2026-2032: A $1.54 Billion Opportunity

Dublin, Feb. 23, 2026 (GLOBE NEWSWIRE) -- The "Microfluidic Components Market - Global Forecast 2026-2032" report has been added to ResearchAndMarkets.com's offering. The microfluidic...
February 23, 2026 09:01 ET | Source: Nucleus Genomics Inc.

Nucleus Upgrades Preview, The First True Glimpse of Your Future Child

Nucleus Preview is a new preconception test for couples that combines rare and chronic disease screening with trait modeling for the first time ever.
February 23, 2026 08:50 ET | Source: Akari Therapeutics Plc

Akari Therapeutics Appoints Globally Recognized Expert in RNA Biology and Cancer Research, Olga Anczukow, Ph.D., to its Scientific Advisory Board

TAMPA, Fla. and LONDON, Feb. 23, 2026 (GLOBE NEWSWIRE) -- Akari Therapeutics, Plc (Nasdaq: AKTX), an oncology biotechnology company developing antibody drug conjugates (ADCs) with novel...
February 23, 2026 08:00 ET | Source: Axonius Inc.

Axonius Appoints Meghan Marks as Chief Marketing Officer to Drive Category Leadership and Market Expansion

Axonius Appoints Meghan Marks as Chief Marketing Officer to Drive Category Leadership and Market Expansion
February 23, 2026 08:00 ET | Source: Artios Pharma

Artios Receives U.S. FDA Fast Track Designation for DNA Polymerase Theta (Polθ) Inhibitor ART6043 for Treatment of gBRCA-mutated HER2-Negative Breast Cancer

Artios receives FDA Fast Track designation for DNA polymerase theta (Polθ) inhibitor ART6043 for treatment of gBRCA-mutated HER2-negative breast cancer
February 23, 2026 07:19 ET | Source: TSplus

TSplus Sets 2030 Vision to Become a Global Reference in Remote Access and Cybersecurity

TSplus has unveiled its strategic roadmap for 2026 during its annual headquarters meeting in Paris, with strong ambitions for 2030.
February 23, 2026 07:00 ET | Source: Tessera Therapeutics

Tessera Therapeutics Receives U.S. FDA Fast Track and Orphan Drug Designations for its Lead In Vivo Gene Editing Program TSRA-196 for the Treatment of Adults with AATD

SOMERVILLE, Mass., Feb. 23, 2026 (GLOBE NEWSWIRE) -- Tessera Therapeutics, the biotechnology company pioneering a new approach in genetic medicine known as Gene Writing™, today announced that the...